CST3 and acute kidney injury: This aligns with Xu et al. [36] and Hidayati et al. [37], who reported that serum cystatin-C is a strong and sensitive biomarker for identifying AKI in neonates and is more sensitive in recognizing patients with a high in-hospital mortality risk than the modified KDIGO creatinine criteria.